11:00 AM
 | 
Oct 19, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Led by ex-Afferent execs, CuraSen raises $54.5M series A

Neurodegenerative disease company CuraSen Therapeutics Inc. (San Mateo, Calif.) raised $54.5 million in a series A round on Oct. 17 led by New Leaf Venture Partners. Also participating were Longitude Capital, funds managed by Tekla Capital, Alta Partners, Johnson & Johnson Innovation - JJDC Inc. and Pappas Capital.

CuraSen's...

Read the full 221 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >